Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11447510B2 · kind B2 · utility
8Cited by
127References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2021 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the large-scale production of psilocybin for use in medicine. Move particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.